News

Could lead to a permanent treatment strategy in the //future . A promising study published in Science Advances suggests that ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
A team of researchers testing an experimental messenger RNA (mRNA) vaccine managed to ramp up the ability of immunotherapy to combat tumors in a stu ...
A group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver ...
The Huntington’s disease mutation worsens over time like a dangerous snowball. By harnessing the power of the gene editing tool CRISPR, scientists may have found a way to interrupt the HD mutation and ...
TAU’s vice president for research and development said that they worked on the project for two-and-a-half years and were very ...
Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...
Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...
Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the ...
Fragile X disorders include two distinct conditions: fragile X syndrome (the most common single-gene cause of developmental ...
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...